GSK was attracted by the research achievements of the university's chemistry academics and its track record of innovation in industry partnerships. GSK associates approached Strathclyde with the intention of establishing a unique research and training platform, as part of a sustained mission of continuous improvement of their drug discovery scientists.
As intended, the research and training endeavours have provided appreciably challenging and prominent scientific and career development opportunities for talented graduate staff, while also establishing a pervasive culture of academic rigour and enhanced scientific excellence within the wider laboratory teams.
Buoyed by these successes, in 2012, the programme was expanded to include further sub-disciplines, as well as to introduce non-GSK employee PhD cohorts, within either GSK or Strathclyde laboratories, with similar collaborative supervision, and the offering of secondments in both directions, providing exposure to both academic and industrial settings.
Overall, the partnership has led to enhanced researcher performance, productivity, rigour, and creativity from the scientists involved, whilst driving the translation of new science from academia into industry (and vice versa). Complementary expertise from each partner has maximised innovation and research performance at GSK, which is catalysing the generation of new and essential healthcare products, has influenced the culture and creativity of individual scientists and collaborative teams, and extensively raised training standards, all leading to broader benefits to the wider healthcare sector with eventual downstream positive impacts on public health.